The effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on body composition in people with type 2 diabetes (T2D) can vary greatly depending on age. This was the focus of a recent study that tracked changes in body mass index (BMI), body fat percentage, and muscle mass over an average of 4. 4 years. The study looked at how these drugs affect different age gr...

A study was conducted to see how well new diabetes medications work. One hundred patients with type 2 diabetes were involved. The focus was on how these drugs affect two specific health markers. The first marker is the ratio of triglycerides to HDL cholesterol. The second is the triglyceride-glucose index. These markers are important because they can indicate he...

Cisplatin is a powerful tool in the fight against cancer. It is a chemotherapy drug that can be very effective. However, it has a downside. It can cause the kidneys to lose too much magnesium. This can lead to a condition called hypomagnesemia. This is a big problem because magnesium is crucial for many bodily functions. Magnesium is vital for the body to function p...

Imagine you have two tough health issues: type 2 diabetes (T2D) and chronic kidney disease (CKD). Doctors are finding new ways to treat these conditions, especially with a special kind of pill called an SGLT2 inhibitor. These pills are getting lots of attention in Europe, Japan, and the US. The FOUNTAIN study (NCT05526157) looked at adults with both T2D and CKD who ...

You might have heard about SGLT2 inhibitors, a type of medicine used to manage type 2 diabetes. But did you know they can increase the risk of genitourinary tract infections? A recent study dug deep into this topic, focusing on both first-time and recurring infections in patients taking these drugs. The research was a retrospective cohort study, meaning it looked bac...